新一代测序与荧光原位杂交鉴定EWSR1基因融合及其新关联
双检测的28例中24例两者均阳性,3例FISH阳性NGS阴性,1例FISH阴性NGS阳性。发现3种新融合:EWSR1/RBFOX2/ERG(尤文肉瘤)、EWSR1/TCF7L2(结肠腺癌)、EWSR1/TFEB(易位相关肾细胞癌)。特定伙伴融合影响组织学诊断和患者管理,靶向NGS优于FISH。
要点
- 靶向NGS比EWSR1分离探针FISH更优,可检测已知和新伙伴融合。
- 新发现EWSR1/TCF7L2融合见于结肠腺癌,EWSR1/TFEB融合见于易位相关肾细胞癌。
- 特定融合伙伴的检测可影响组织学诊断和患者管理。
核心结论
- 靶向NGS Fusion assay在检测已知和新EWSR1重排及融合伙伴方面优于EWSR1分离探针FISH。
- 识别特定融合伙伴对组织学诊断和患者管理有影响。
研究设计与样本
- 融合检测采用分离探针FISH和/或临床RNA-based fusion transcript检测(NGS)。
- 28例同时接受FISH和NGS检测,24例仅FISH,11例仅NGS。
主要发现
- 双检测的28例中,24例两种方法均阳性,3例FISH阳性但NGS阴性,1例FISH阴性但NGS阳性。
- 发现3种新融合:EWSR1/RBFOX2/ERG(尤文肉瘤)、EWSR1/TCF7L2(结肠腺癌)、EWSR1/TFEB(易位相关肾细胞癌)。
- 结肠腺癌和肾细胞癌此前未与EWSR1重排关联。
临床怎么用
- 在检测EWSR1重排及融合伙伴时,优先考虑靶向NGS-based fusion assay而非仅用分离探针FISH。
- 检测特定融合伙伴有助于明确诊断和指导治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
EWSR1 is a 'promiscuous' gene that can fuse with many different partner genes in phenotypically identical tumors or partner with the same genes in morphologically and behaviorally different neoplasms. Our study set out to examine the EWSR1 fusions identified at our institution over a 3-year period, using various methods, their association with specific entities and possible detection of novel partners and associations. Sixty-three consecutive cases investigated for EWSR1 gene fusions between 2015 and 2018 at our institution were included in this study. Fusions were identified by either break-apart fluorescence in-situ hybridization (FISH), our clinical RNA-based assay for fusion transcript detection or both. Twenty-eight cases were concurrently tested by FISH and NGS, 24 were tested by FISH alone and 11 by NGS alone. Of the 28 cases with dual testing, 24 were positive by both assays for an EWSR1 gene fusion, 3 cases were discordant with a positive FISH assay and a negative NGS assay, and 1 case was discordant with a negative FISH assay but a positive NGS assay. Three novel fusions were identified: a complex rearrangement involving three genes (EWSR1/RBFOX2/ERG) in Ewing sarcoma, a EWSR1/TCF7L2 fusion in a colon adenocarcinoma, and a EWSR1/TFEB fusion in a translocation-associated renal cell carcinoma. Both colonic adenocarcinoma and renal cell carcinoma had not been previously associated with EWSR1 rearrangements to our knowledge. In a subset of cases, detection of a specific partner had an impact on the histological diagnosis and patient management. In our experience, the use of a targeted NGS-based fusion assay is superior to EWSR1 break-apart FISH for the detection of known and novel EWSR1 rearrangements and fusion partners, particularly given the emerging understanding that distinct fusion partners result in different diseases with distinct prognostic and therapeutic implications.
引用
- Krystel-Whittemore M, Taylor MS, Rivera M, et al. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization. Hum Pathol. 2019. PMID: 31430493. doi:10.1016/j.humpath.2019.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。